Roger Stupp, MD, discusses final results of a randomized, multi-center, phase III trial investigating tumor treating fields added to standard chemotherapy in newly diagnosed glioblastoma.
Roger Stupp, MD
Advertisement
Articles by Roger Stupp, MD
Results from the EF-14 trial which compared standard of care for glioblastoma plus or minus the tumor treating fields.
Advertisement
Latest Updated Articles
Adding TTFields to Chemotherapy to Improves Survival in GlioblastomaJanuary 18th 2018
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Insurance Delays and Travel Strain CAR T Referral in Early Relapsed Myeloma
2
NCCN Guidelines Add Cosibelimab for Locally Advanced CSCC
3
Real-World Data for Darolutamide vs Abiraterone Triplet Therapy in mHSPC
4
Sofetabart Mipitecan Elicits Responses Across FRα Levels in Ovarian Cancer
5